Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 875-881

  Ninomiya, Haruhiko ^a   Kawashima, Yasuko ^a   Nagasawa, Toshiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

C5b6; Complement; Heparin; Low molecular weight heparin; Paroxysmal nocturnal haemoglobinuria

Indexed keywords

COMPLEMENT COMPONENT C1; DALTEPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; BIOTINYLATION; COMPLEMENT INHIBITION; HEMOLYSIS; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHOBICITY; MOLECULAR INTERACTION; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL;

ANTICOAGULANTS; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; DEPRESSION, CHEMICAL; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS;

EID: 0033867797     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02125.x     Document Type: Article

References (27)

1. Baker, P.J., Lint, T.F., McLeod, B.C., Behrends, C.L. & Gewurz, H. (1975) Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis by polyanions and polycations. Journal of Immunology, 114, 554-558.
2. Caughman, G.B., Boackle, R.J. & Vesely, J. (1982) A postulated mechanism for heparins potentiation of C1 inhibitor function. Molecular Immunology, 19, 287-295.
3. Crosby, W.H. & Dameshek, W. (1950) Paroxysmal nocturnal hemoglobinuria. The mechanism of hemolysis and its relation to the coagulation system. Blood, 5, 822-842.
4. Esser, A.F. (1994) The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology, 87, 229-247.
5. Fiore, L. & Deykin, D. (1995) Anticoagulant therapy. In: Wiliams Hematology, 5th edn (ed. by E. Beutler, M.A. Lichtman, B.S. Coller, & T.J. Kipps), pp. 1562-1584. McGraw-Hill, New York.
6. Hartmann, R.C., Jenkins, D.E.J. & Arnold, A.B. (1970) Diagnostic specificity of sucrose hemolysis test for paroxysmal nocturnal hemoglobinuria. Blood, 35, 462-475.
7. Hu, V.W., Esser, A.F., Podack, E.R. & Wisnieski, B.J. (1981) The membrane attack mechanism of complement: photolabeling reveals insertion of terminal proteins into target membrane. Journal of Immunology, 127, 380-386.
8. Jaques, L.B. (1985) The new understanding of the drug heparin. Chest, 88, 751-754.
9. Jenkins, Jr, D.E., Hartmann, R.C. & Kern, A.L. (1967) Serum-red cell interactions at low ionic strength: erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells. Journal of Clinical Investigation, 46, 753-761.
10. Kazatchkine, M.D., Fearon, D.T., Metcalfe, D., Rosenberg, R.D. & Austen, K.F. (1981) Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase. Journal of Clinical Investigation, 67, 223-228.
11. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
12. Lennick, M., Brew, S.A. & Ingham, K.C. (1986) Kinetics of interaction of C1 inhibitor with complement C1s. Biochemistry, 25, 3890-3898.
13. Liu, C., Marshall, P., Schreibman, I., Vu, A., Gai, W. & Whitlow, M. (1999) Interaction between terminal complement proteins C5b-7 and anionic phospholipids. Blood, 93, 2297-2301.
14. Logue, G.L. (1977) Effect of heparin on complement activation and lysis of paroxysmal nocturnal hemoglobinuria (PNH) red cells. Blood, 50, 239-247.
15. Loos, M., Volanakis, E. & Stroud, R.M. (1976a) Mode of interaction of different polyanions with the first (C1, C1) the second (C2) and the fourth (C4) component of complement - II. Immunochemistry, 13, 257-261.
16. Loos, M., Volanaski, J.E. & Stroud, R.M. (1976b) Mode of interaction of different polyanions with the first (C1, C1) the second (C2) and the fourth (C4) component of complement - III. Immunochemistry, 13, 789-791.
17. Maillet, F., Petitou, M., Choay, J. & Kazatchkine, M.D. (1988) Structure-function relationships in the inhibitory effect of heparin on complement activation: independence of the anti-coagulant and anti-complementary sites on the heparin molecule. Molecular Immunology, 25, 917-923.
18. Marshall, P., Hasegawa, A., Davidson, E.A., Nussenzweig, V. & Whitlow, M. (1996) Interaction between complement proteins C5b-7 and erythrocyte membrane sialic acid. Journal of Experimental Medicine, 184, 1225-1232.
19. Nilsson, T. & Wiman, B. (1983) Kinetics of the reaction between human C1 esterase inhibitor and C1r or C1s. European Journal of Biochemistry, 129, 663-667.
20. Ninomiya, H., Kawashima, Y., Hasegawa, Y. & Nagasawa, T. (1999) Complement-induced procoagulant alteration of red blood cell membranes with microvesicle formation in paroxysmal nocturnal haemoglobinuria (PNH): implication for thrombogenesis in PNH. British Journal of Haematology, 106, 224-231.
21. Raepple, E., Hill, H.-U. & Loos, M. (1976) Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement - I. Immunochemistry, 13, 251-255.
22. Rent, R., Myhrman, R., Fiedel, A. & Gewurz, H. (1976) Potentiation of C1 esterase inhibitory activity by heparin. Clinical and Experimental Immunology, 23, 264-271.
23. Rosse, W.F. & Ware, R.E. (1995) The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood, 86, 3277-3286.
24. Silversmith, R.E. & Nelsestuen, G.L. (1986) Interaction of complement proteins C5b-6 and C5b-7 with phospholipid vesicles: effects of phospholipid structural features. Biochemistry, 25, 7717-7725.
25. Weiler, J.M., Edens, R.E., Linhardt, R.J. & Kapelanski, D.P. (1992) Heparin and modified heparin inhibit complement activation in vivo. Journal of Immunology, 148, 3210-3215.
26. Wuillemin, W.A., te Velthuis, H., Lubbers, Y.T., de Ruig, C.P., Eldering, E. & Hack, C.E. (1997) Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma. Journal of Immunology, 159, 1953-1960.
27. Ziccardi, R.J. & Cooper, N.R. (1979) Active disassembly of the first complement component, C1, by C1 inactivator. Journal of Immunology, 123, 788-792.